{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:17:31Z","timestamp":1791141451049,"version":"4.1.0"},"reference-count":31,"publisher":"EDP Sciences","issue":"8-9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1051\/medsci\/2010268-8761","type":"journal-article","created":{"date-parts":[[2011,3,3]],"date-time":"2011-03-03T08:29:32Z","timestamp":1299140972000},"page":"761-767","source":"Crossref","is-referenced-by-count":10,"title":["Des nanovecteurs hybrides pour la restitution retard de m\u00e9dicaments antitumoraux et antiviraux"],"prefix":"10.1051","volume":"26","author":[{"given":"Patricia","family":"Horcajada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Serre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"F\u00e9rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Couvreur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Gref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2010,8,15]]},"reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Peer D, Karp JM, Hong S,et al. Nanocarriers as an emerging platform for cancer therapy.Nat Nanotechnol2007 ; 2 : 751-60.","DOI":"10.1038\/nnano.2007.387"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Couvreur P, Gref R, Andrieux K, Malvy C. Nanotechnology for drug delivery: Applications to cancer and autoimmune diseases.Prog Solid State Chem2006 ; 34 : 231-5.","DOI":"10.1016\/j.progsolidstchem.2005.11.009"},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Gref R, Minamitake Y, Peracchia MT,et al. Biodegradable long-circulating polymeric nanospheres.Science1994 ; 263 : 1600-3.","DOI":"10.1126\/science.8128245"},{"key":"R4","unstructured":"Gabizon A. Stealth liposomes and tumor targeting: One step further in the quest for the magic bullet.Clin Cancer Res2001 ; 7 : 223-5."},{"key":"R5","doi-asserted-by":"crossref","unstructured":"Hasan AS, Socha M, Lamprecht A,et al. Effect of the microencapsulation of nanoparticles on the reduction of burst release.Int J Pharm2007 ; 344 : 53-61.","DOI":"10.1016\/j.ijpharm.2007.05.066"},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Gref R, Minamitake Y, Peracchia MT,et al. Biodegradable long-circulating polymeric nanospheres.Science1994 ; 263 : 1600-3.","DOI":"10.1126\/science.8128245"},{"key":"R7","doi-asserted-by":"crossref","unstructured":"Couvreur P, Stella B, Reddy LH,et al. Squalenoyl nanomedicines as potential therapeuticsNano Lett2006 ; 6 : 2544-8.","DOI":"10.1021\/nl061942q"},{"key":"R8","doi-asserted-by":"crossref","unstructured":"F\u00e9rey G. Hybrid porous solids: past, present, future.Chem Soc Rev2008 ; 37 : 191-241.","DOI":"10.1039\/B618320B"},{"key":"R9","doi-asserted-by":"crossref","unstructured":"F\u00e9rey G, Serre C. Large breathing effects in three-dimensional porous hybrid matter: facts, analyses, rules and consequences.Chem Soc Rev2009 ; 38 :1380-99.","DOI":"10.1039\/b804302g"},{"key":"R10","doi-asserted-by":"crossref","unstructured":"Llewellyn PL, Bourrelly S, Serre C,et al. High uptakes of CO2 and CH4 in mesoporous metal organic frameworks MIL-100 and MIL-101.Langmuir2008 ; 24 : 7245-50.","DOI":"10.1021\/la800227x"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Horcajada P, Serre C, Vallet-Regf M,et al. Metal_organic frameworks as efficient materials for drug delivery.Angew Chem Int Ed Engl2006 ; 45 : 5974-8.","DOI":"10.1002\/anie.200601878"},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Horcajada P, Serre C, Maurin G,et al. Flexible porous metal organic frameworks for a controlled drug delivery.J Am Chem Soc2008 ; 130 : 6774-80.","DOI":"10.1021\/ja710973k"},{"key":"R13","unstructured":"Horcajada P, Serre C, Gref R,et al. Nanoparticules hybrides organiques inorganiques \u00e0 base de carboxylates de fer.PCT applicationsPCT\/FR2008\/001366, 1eroctobre 2008."},{"key":"R14","unstructured":"Horcajada P, Serre C, Gref R,et al. Solides hybrides organique-inorganique \u00e0 surface modifi\u00e9e.PCT applicationsPCT\/FR2008\/001367, 1eroctobre 2008."},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Sheftel VO.Indirect food additives and polymers: migration and toxicology. Boca Raton : Lewis Publishers, 2000 : 148-54.","DOI":"10.1201\/9781482293821"},{"key":"R16","unstructured":"http:\/\/www.chem.unep.ch\/irptc\/sids\/0ECDSIDS\/100-21-0.pdf> (2008)."},{"key":"R17","unstructured":"http:\/\/www.chemicalland21.com\/specialtychem\/perchem\/TRIMESIC %20ACID.htm> (2008)."},{"key":"R18","unstructured":"http:\/\/www.sciencelab.com\/xMSDS-Fumaric_acid-9927173> (2008)."},{"key":"R19","doi-asserted-by":"crossref","unstructured":"Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.J Immunol Methods1983 ; 65 : 55-63.","DOI":"10.1016\/0022-1759(83)90303-4"},{"key":"R20","doi-asserted-by":"crossref","unstructured":"Vauthier C, Dubernet C, Chauvierre C,et al. Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.J Control Release2003 ; 93 : 151-60.","DOI":"10.1016\/j.jconrel.2003.08.005"},{"key":"R21","doi-asserted-by":"crossref","unstructured":"Vassal G, Deroussent A, Challine D,et al. Is 600mg.m\u22122the appropriate dosage of busulfan in children undergoing bone marrow transplantation?Blood1992 ; 79 : 2475-9.","DOI":"10.1182\/blood.V79.9.2475.bloodjournal7992475"},{"key":"R22","doi-asserted-by":"crossref","unstructured":"Vassal G, Gouyette A, Hartmann O,et al. Pharmacokinetics of high-dose busulfan in children.Cancer Chemother Pharmacol1989 ; 24 : 386-90.","DOI":"10.1007\/BF00257448"},{"key":"R23","unstructured":"Slattery JT, Sanders JE, Buckner CD,et al. Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.Bone Marrow Transplant1995 ; 16 : 31-42."},{"key":"R24","unstructured":"Layre A, Gref R, Richard J,et al. Nanoparticules polym\u00e9riques composites. FR 04 07569, 7 juillet 2004."},{"key":"R25","doi-asserted-by":"crossref","unstructured":"Hassan Z, Nilsson C, Hassan M. Liposomal busulphan: bioavailability and effect on bone marrow in mice.Bone Marrow Transplant1998 ; 22 : 913-8.","DOI":"10.1038\/sj.bmt.1701458"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Thierry AR, Vig\u00e9 D, Coughlin SS,et al. Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes.FASEB J1993 ; 7 : 572-9.","DOI":"10.1096\/fasebj.7.6.8097173"},{"key":"R27","doi-asserted-by":"crossref","unstructured":"Loke SL, Stein CA, Zhang XH,et al. Characterization of oligonucleotide transport into living cells.Proc Natl Acad Sci USA1989 ; 86 : 3474-8.","DOI":"10.1073\/pnas.86.10.3474"},{"key":"R28","doi-asserted-by":"crossref","unstructured":"Kukhanova M, Krayevsky A, Prusoff W, Cheng YC. Design of anti-HIV compounds: From nucleoside to nucleoside 50-triphosphate analogs. Problems and perspectives.Curr Pharm Des2000 ; 6 : 585-98.","DOI":"10.2174\/1381612003400687"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Hillaireau H, Le Doan T, Besnard M,et al. Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(isobutyl cyanoacrylate) nanocapsules.Int J Pharm2006 ; 324 : 37-42.","DOI":"10.1016\/j.ijpharm.2006.07.006"},{"key":"R30","doi-asserted-by":"crossref","unstructured":"Taylor KM, Jin A, Lin W. Surfactant-assisted synthesis of nanoscale gadolinium metal_organic-framework for potential multimodal imaging.Angew Chem Int Ed Engl2008 ; 47 : 7722-5.","DOI":"10.1002\/anie.200802911"},{"key":"R31","doi-asserted-by":"crossref","unstructured":"Horcajada P, Chalati T, Serre C,et al. Porous metal-organic framework nanoscale carriers as a potential platform for drug delivery and imaging.Nat Mater2010 ; 9 : 172-8.","DOI":"10.1038\/nmat2608"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2010268-8761\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T01:19:03Z","timestamp":1592356743000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/2010268-8761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":31,"journal-issue":{"issue":"8-9"},"alternative-id":["medsci2010268-9p761"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2010268-8761","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}